1. BONE MARROW INVOLVEMENT, BUT NO BLOOD INVOLVEMENT, IMPAIRS SURVIVAL IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: AN ANCILLARY STUDY OF THE REVAIL TRIAL. (12th June 2019) Authors: Lemonnier, F.; Safar, V.; Ferchiou, A.; Cottereau, A.; Bachy, E.; Cartron, G.; Moles‐Moreau, M.; Delmer, A.; Bouabdallah, R.; Voillat, L.; Parrens, M.; Casasnovas, O.; Cacheux, V.; Réguy, C.; Tilly, H.; Meignan, M.; Gaulard, P.; de Leval, L.; Delfau‐Larrue, M.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY. (12th June 2019) Authors: Cottereau, A.; Vercellino, L.; Casasnovas, O.; Tilly, H.; Feugier, P.; Fruchart, C.; Roulin, L.; Oberic, L.; Pica, G.; Ribrag, V.; Abraham, J.; Simon, M.; Gonzalez, H.; Bouabdallah, R.; Fitoussi, O.; Sebban, C.; Lopez, A.; Macro, M.; Sahnes, L.; Morschhauser, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INTEGRATIVE ANALYSIS OF FEATURES ASSOCIATED WITH TET2, IDH2, DNMT3A, AND RHOA MUTATIONS IN ANGIOIMMUNOBLASTIC T CELL LYMPHOMA: A LYSA STUDY. (June 2017) Authors: Lemonnier, F.; Safar, V.; Cottereau, A.; Fataccioli, V.; Chaillol, I.; Pelletier, R.; Letourneau, A.; Dupuy, A.; Bossard, C.; Martin, A.; Robe, C.; Pelletier, L.; Pujals, A.; Bachy, E.; Delmer, A.; Moles Moreau, M.; Tilly, H.; Parrens, M.; Delfau‐Larue, M.; Missiaglia, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PROGNOSTIC MODEL FOR HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA INCLUDING BASELINE TOTAL METABOLIC TUMOR VOLUME AND END INDUCTION PET: a POOLED ANALYSIS FROM LYSA AND FIL TRIALS. (June 2017) Authors: Cottereau, A.; Versari, A.; Dupuis, J.; Chartier, L.; Menga, M.; Casasnovas, R.; Haioun, C.; Tilly, H.; Tarantino, V.; Dubreuil, J.; Federico, M.; Salles, G.; Luminari, S.; Trotman, J.; Meignan, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PROGNOSTIC VALUE OF BASELINE TOTAL METABOLIC TUMOR VOLUME (TMTV) FOR PATIENTS WITH EARLY STAGE HODGKIN LYMPHOMA ENROLLED IN THE STANDARD ARM OF THE H10 (EORTC/LYSA/FIL) TRIAL. (June 2017) Authors: Cottereau, A.; Versari, A.; Loft, A.; Casasnovas, R.; Bellei, M.; Ricci, R.; Bardet, S.; Castagnoli, A.; Brice, P.; Raemaekers, J.; Deau, B.; Fortpied, C.; Raveloarivahy, T.; Girinsky, T.; Van Zele, E.; Vander Borght, T.; Federico, M.; Hutchings, M.; Ricardi, U.; Andre, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗